Breast Cancer - Alfa Cytology

Alfa Cytology is a specialized research solutions provider, with a primary focus on the development of therapeutic interventions for breast cancer and conducting preclinical studies. From the intricate stages of target discovery to IND application, we offer a seamless and comprehensive experience.

As a dedicated provider of preclinical research services with a specific focus on breast cancer, Alfa Cytology‘s comprehensive drug discovery solutions and diverse range of cutting-edge technology platforms will effectively cater to the unique requirements of our esteemed clients, ensuring the delivery of innovative and impactful research outcomes.

Alfa Cytology specializes in providing comprehensive and efficient preclinical research services to meet the diverse needs of drug development, encompassing drug efficacy studies, pharmacokinetic studies, drug safety evaluations, among others.

Professional

We have top scientific researchers, oncologists, and the most professional service team.

Experienced

Since our establishment, we have been committed to providing professional services to oncology researchers around the world.

Efficient

Our team works closely together and is passionate about completing every task assigned by our customers.

ABOUT US

Alfa Cytology is committed to providing customers with comprehensive support in the fields of biological, chemical and pharmaceutical research. Our team, comprised of seasoned professionals, collaborates with researchers to efficiently conduct breast cancer studies, exploring innovative approaches for both diagnosis and treatment.

Most Common Breast Cancer Types

We offer specialized services to address the unique needs of different breast cancer types, ensuring targeted and effective treatments.

Invasive
Breast Cancer

Non-invasive Breast
Cancer

Triple-Negative Breast
Cancer

Inflammatory Breast
Cancer (IBC)

Medullary Breast
Carcinoma

Mucinous Breast
Carcinoma

Tubular Breast
Carcinoma

Papillary Breast
Carcinoma

Molecule-Driven Breast Cancer Therapies

We develop various molecular therapies to offer innovative breast cancer treatments.

Small Molecule Drug

Comprehensive services for developing small molecule drugs that offer targeted and efficient treatment options for breast cancer.

Therapeutic Antibody

Cutting-edge solutions for creating therapeutic antibodies that specifically target breast cancer cells.

Gene Therapy

Advanced gene therapy development services aimed at altering genetic material to treat or prevent breast cancer.

Cell Therapy

Innovative cell therapy solutions for breast cancer, leveraging immune cells like CAR-T and NK cells to precisely target and eliminate cancer cells.

Peptidomimetic

Targeted development of peptidomimetic drugs that mimic natural peptides, offering enhanced stability and effectiveness against breast cancer.

Vaccine

Advanced vaccine development services focused on creating therapeutic vaccines to stimulate the immune system to fight breast cancer.

Targets and Pathways

Focused on developing drugs that target specific breast cancer markers to enhance treatment precision.

HER2 Inhibitor

Immune Checkpoint Inhibitor

CDK4/6 Inhibitor

PARP Inhibitor

PI3K/AKT/mTOR Pathway Inhibitor

Angiogenesis Inhibitor

AR-targeted Therapy

ERK/MAPK Pathway Inhibitor

HDAC Inhibitor

BET Inhibitor

Comprehensive Breast Cancer Research Services

Supporting all phases of breast cancer research, from diagnostics to basic studies.

Diagnostics Development

Tailored Biomarker Identification
Multi-Omic Analysis
AI Diagnosis for Breast Cancer

Cell Line Development
3D Tumor Model
Animal Modeling Services

Efficacy Evaluation
ADME Evaluation
Toxicological Profiling

Pathology Services
Cell Analysis Services
Microbiota Analysis Services

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies